Neoadjuvant chemotherapy for pancreatic cancer: Quality over quantitySam Z. Thalji, Susan Tsai, Bradley A. Erickson et al.|Journal of Surgical Oncology|2023Cited by 4
Biliary Adverse Events During Neoadjuvant Therapy for Pancreatic CancerSam Z. Thalji, Susan Tsai, Deemantha G. Fernando et al.|Annals of Surgery|2023Cited by 4
Abstract PO-055: Phase II clinical trial of subtype directed neoadjuvant therapy in patients with localized pancreatic cancerSusan Tsai, Jen Jen Yeh, Erkut Borazanci et al.|Cancer Research|2021Cited by 3